Bipartisan group of senators urge coverage of CT lung cancer screening

A group of 44 senators, led by Dianne Feinstein (D-Calif.) and Johnny Isakson (R-Ga.), have signed a letter asking Marilyn Tavenner, administrator for the Centers for Medicare and Medicaid Services (CMS), to extend coverage of low-dose CT screening to Medicare beneficiaries at high risk of lung cancer.

“It is our hope that fully utilizing this screening tool as appropriate based on patient risk factors will help reduce the more than 156,000 deaths due to lung cancer in the United States each year,” read the letter.

The senators noted the median age of lung cancer diagnosis is 70, underscoring the importance of coverage for seniors on Medicare.

Currently, low-dose CT screening is becoming available through private insurance coverage, though CMS is still debating whether to provide coverage to Medicare beneficiaries. In April, a panel convened by the Medicare Evidence Development & Coverage Advisory Committee indicated it had low confidence that the evidence supported low-dose CT screening in a Medicare-aged population. A draft decision will be made later this year.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.